Company facts
- Headquarters
- Alameda, California
- Most recent report
- 10-Q, filed Sep 2, 2026
- Incorporated
- Delaware
- Filings on record
- 46 filings
- On EDGAR
- CIK 1853921
- Fiscal year ends
- December
- Filer status
- Non-accelerated filer, Smaller reporting company, Emerging growth company
Financials 1
News 2
Prospectuses and Registrations 6
- S-8 Registration statement for an employee plan Jul 27, 2026
- 424B4 Final prospectus for an offering Jul 27, 2026
- FWP Free writing prospectus Jul 24, 2026
- S-1/A Registration statement for an offering, amended Jul 20, 2026
- S-1/A Registration statement for an offering, amended Jul 10, 2026
- S-1 Registration statement for an offering Jul 2, 2026
Ownership 8 of 29
- SCHEDULE 13G Large holder reported a passive stake Aug 3, 2026
- SCHEDULE 13D Large holder reported an active stake Jul 30, 2026
- SCHEDULE 13D Large holder reported an active stake Jul 30, 2026
- 4 Insider reported a trade Jul 29, 2026
- 4 Insider reported a trade Jul 29, 2026
- 4 Insider reported a trade Jul 29, 2026
- SCHEDULE 13D Large holder reported an active stake Jul 29, 2026
- 4 Insider reported a trade Jul 29, 2026
Other 8
- EFFECT Notice that a registration became effective Jul 23, 2026
- S-1MEF Jul 23, 2026
- CERT Exchange certified a listing Jul 22, 2026
- 8-A12B Registration of a security for exchange listing Jul 21, 2026
- DRS/A Draft registration statement, submitted confidentially, amended Jun 12, 2026
- DRS/A Draft registration statement, submitted confidentially, amended Mar 6, 2026
- DRS Draft registration statement, submitted confidentially Jan 9, 2026
- D Apr 2, 2021
Everything here comes from Scribe Therapeutics, Inc.'s own filings on SEC EDGAR. The filing list is rechecked every hour.